HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Xiaolong Jiao Mark J. Krasna Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jiao, X. Articles by Krasna, M. J. Search for Related Content PubMed PubMed Citation Articles by Jiao, X. Articles by Krasna, M. J. Related Collections Lung - cancer

Ann Thorac Surg 2002;74:278-284
© 2002 The Society of Thoracic Surgeons

---

Review

Clinical significance of micrometastasis in lung and esophageal cancer: a new paradigm in thoracic oncology

^a Division of Thoracic Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA

* Address reprint requests to Dr Jiao, Division of Thoracic Surgery, University of Maryland Medical System, Rm N4E35, 22 S Greene St, Baltimore, MD 21201 USA
e-mail: xjiao{at}smail.umaryland.edu

In the past decade, detection of micrometastatic disease in different clinical samples including pleural lavage, lymph node, bone marrow, and blood has become a rapidly growing area of interest in research of non-small cell lung cancer and esophageal cancer. The results of these studies support the concept that, just as in many other solid malignancies, systemic spread may happen at an early stage in non-small cell lung cancer and esophageal cancer. Such systemic spread is often occult (micrometastases) at the time of primary diagnosis, which may have adverse effects on survival. Improved staging can be expected with information on micrometastases, and a subgroup of patients who will benefit most from adjuvant therapy might be identified. Although reliable and standard methods need to be developed before detection of micrometastasis is incorporated in the routine clinical practice, we suggest that it be considered an important correlate in clinical trials in non-small cell lung cancer and esophageal cancer.

This article has been cited by other articles:

				M. Riquet, P. Bagan, F. Le Pimpec Barthes, E. Banu, F. Scotte, C. Foucault, A. Dujon, and C. Danel Completely Resected Non-Small Cell Lung Cancer: Reconsidering Prognostic Value and Significance of N2 Metastases Ann. Thorac. Surg., December 1, 2007; 84(6): 1818 - 1824. [Abstract] [Full Text] [PDF]

				A. M. Schwartz and D. E. Henson Diagnostic Surgical Pathology in Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 78S - 93S. [Abstract] [Full Text] [PDF]

				G. A. Silvestri, M. K. Gould, M. L. Margolis, L. T. Tanoue, D. McCrory, E. Toloza, and F. Detterbeck Noninvasive Staging of Non-small Cell Lung Cancer: ACCP Evidenced-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 178S - 201S. [Abstract] [Full Text] [PDF]

				C. Nwogu, G. Fischer, D. Tan, M. Glinianski, D. Lamonica, and T. Demmy Radioguided Detection of Lymph Node Metastasis in Non-Small Cell Lung Cancer Ann. Thorac. Surg., November 1, 2006; 82(5): 1815 - 1820. [Abstract] [Full Text] [PDF]

				F.-Y. Liu, J. T. Chang, H.-M. Wang, C.-T. Liao, C.-J. Kang, S.-K. Ng, S.-C. Chan, and T.-C. Yen [18F]Fluorodeoxyglucose Positron Emission Tomography Is More Sensitive Than Skeletal Scintigraphy for Detecting Bone Metastasis in Endemic Nasopharyngeal Carcinoma at Initial Staging J. Clin. Oncol., February 1, 2006; 24(4): 599 - 604. [Abstract] [Full Text] [PDF]

				D. Kim, W. Ryu, S. J. Cho, J. Kim, and S. Park Touch print cytology shows higher sensitivity than pleural lavage cytology for pleural micro-metastasis in lung cancer Interactive CardioVascular and Thoracic Surgery, February 1, 2005; 4(1): 70 - 74. [Abstract] [Full Text] [PDF]

				G. M. Spence, A. N. J. Graham, K. Mulholland, P. Maxwell, W. G. McCluggage, J. M. Sloan, and J. A. McGuigan Bone Marrow Micrometastases and Markers of Angiogenesis in Esophageal Cancer Ann. Thorac. Surg., December 1, 2004; 78(6): 1944 - 1949. [Abstract] [Full Text] [PDF]

				M. B. Faries, R. J. Bleicher, X. Ye, R. Essner, and D. L. Morton Lymphatic Mapping and Sentinel Lymphadenectomy for Primary and Metastatic Pulmonary Malignant Neoplasms Arch Surg, August 1, 2004; 139(8): 870 - 877. [Abstract] [Full Text] [PDF]

				E. Lim, A. Ali, P. Theodorou, A. G. Nicholson, G. Ladas, and P. Goldstraw Intraoperative pleural lavage cytology is an independent prognostic indicator for staging non-small cell lung cancer J. Thorac. Cardiovasc. Surg., April 1, 2004; 127(4): 1113 - 1118. [Abstract] [Full Text] [PDF]

				X. Jiao, A. Eslami, O. Ioffe, K. F. Kwong, M. Henry, Q. Zeng, Y. Refaely, W. Burrows, Z. Gamliel, and M. J. Krasna Immunohistochemistry analysis of micrometastasis in pretreatment lymph nodes from patients with esophageal cancer Ann. Thorac. Surg., October 1, 2003; 76(4): 996 - 1000. [Abstract] [Full Text] [PDF]

				H. Skuladottir and J. H. Olsen Conditional Survival of Patients With the Four Major Histologic Subgroups of Lung Cancer in Denmark J. Clin. Oncol., August 15, 2003; 21(16): 3035 - 3040. [Abstract] [Full Text] [PDF]